About
With over 20 years of international experience in clinical development, medical strategy, and market access across biotech and pharma, I bring deep expertise in translating science into strategic and operational impact in US, EU and APAC. My background in advanced therapies, biopharmaceuticals, and eHealth innovation positions me to effectively bridge medical, digital, and business domains. As an experienced cross-functional leader, I know how to connect clinical data, stakeholder engagement, and technological innovation to drive sustainable healthcare solutions. This combination of scientific depth, strategic insight, and leadership makes me a valuable advisor for biopharma and eHealth Tech initiatives.
Biopharma and eHealth-Tech companies developing advanced therapies or integrating digital innovation can greatly benefit from my expertise. Organizations such as UCB, J&J, Teva, Miltenyi and many other biopharma companies could leverage my experience in clinical development, medical strategy, and cross-functional leadership across EU, US, APAC and global settings. I bring proven ability to align science, regulatory strategy, and real-world evidence to accelerate product development and access. My background also adds value to digital health and AI-driven biotechs where medical and data integration are key to success.
Biopharma and eHealth-Tech companies developing advanced therapies or integrating digital innovation can greatly benefit from my expertise. Organizations such as UCB, J&J, Teva, Miltenyi and many other biopharma companies could leverage my experience in clinical development, medical strategy, and cross-functional leadership across EU, US, APAC and global settings. I bring proven ability to align science, regulatory strategy, and real-world evidence to accelerate product development and access. My background also adds value to digital health and AI-driven biotechs where medical and data integration are key to success.
Wim Weyenberg, PhD is an advisor and board member based in Belgium, specialising in Pharmaceuticals. They speak Dutch, English and French. They are open to advisory board and board director opportunities and are available for introductions through Boardio.
Boardio matches companies with experienced advisors and board members across 120 countries — this is one of 12k+ profiles in the network.
Looking for advisors?
Browse now
Interested in becoming an advisor?
See opportunities